The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension
Links shared publicly online about this topic.
- 473total visits
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension
View full resource at tar.sagepub.com
Tags: Heart Disease, High Blood Pressure, Pulmonology
Most Recently Shared on February 28, 2011 at 5:01 pm By:
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension. http://bit.ly/e7wEZD
United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
ir.unither.com — “United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension” View full resource at ir.unither.com
Most Recently Shared on July 31, 2009 at 1:12 pm By:
Dr. Warren Rosenblum Physician, Doctor, Internist, and Cardiologist
FDA approves inhaled Treprostinil (Tyvaso) for the treatment of Pulmonary Hypertension. http://tinyurl.com/kw89ks
FDA Approves Tyvaso (treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
drugs.com — “Tyvaso (treprostinil) is used to treat Pulmonary Arterial Hypertension. Includes Tyvaso side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 31, 2009 at 3:51 am By:
FDA Approves Tyvaso (treprostinil) Inhalation Solution for Pulmonary Arterial Hypertension - http://bit.ly/w1huZ
Tyvaso approved for pulmonary arterial hypertension (PAH) - MPR
empr.com — “The FDA has approved Tyvaso (treprostinil inhalation solution, from United Therapeutics), a prostacyclin vasodilator, for the treatment of pulmonary arterial hypertension (PAH) using the Tyvaso Inhalation System.” View full resource at empr.com
Most Recently Shared on July 30, 2009 at 8:18 pm By:
MPR News: Tyvaso approved for pulmonary arterial hypertension (PAH): The FDA has approved Tyvaso (trepr.. http://bit.ly/UGQxc
Advertisement
